Cormac M. J. Linehan

Suggest Changes
  • Citations Per Year
Learn More
TPS116 Background: Despite advances in the treatment of HER2 overexpressed MBC, nearly all patients develop progressive disease and innovative well-tolerated HER2-directed therapies are needed. T-DM1(More)
  • 1